共 8 条
[1]
The use of recombinant human B-type natriuret-ic peptide(nesiritide)in the management of acute decom-pensated heart failure. Strain WD. International Journal of Clinical Practice . 2004
[2]
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary. Karl S.John C,Wilson,S,et al. European Heart Journal . 2005
[3]
Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure. Elkayam,U,Akhter,MW,Singh,H,Khan,S,Usman,A. The American Journal of Cardiology . 2004
[4]
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Colucci WS,Elkayam U,Horton DP,et al. The New England Journal of Medicine . 2000
[5]
Safety and effectiveness of dofetilide for conversion ofatrial fibrillation and nesiritide for acute decompensation of heartfailure. GR INES CL. C ircu lation . 2001
[6]
Brain natriuretic peptide in the management of heart failure: the versatile neurohormone. de,Denus,S,Pharand,C,Williamson,DR. Chest . 2004
[7]
Intravenous nesiritide vs.nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. Young JB,Abraham WT,Stevenson LW,et al. The Journal of The American Medical Association . 2002